Illudent Therapeutics
- Biotech or pharma, therapeutic R&D
lludent is developing drugs to treat solid tumors with specific defects in the DNA Damage Repair system (DDR), specifically the 10% of solid tumors that carry mutations in the Transcription-Coupled Nucleotide Excision Repair (TC-NER) pathway.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}